Fri 29 March 2024
Warszawa (PL)
7/7°C
Wed
|
Thu
|
Fri
|
Sat
|
Sun
|
16 |
18 |
16 |
23 |
22 |
Fri 29 March 2024
Praha (CZ)
4/5°C
Wed
|
Thu
|
Fri
|
Sat
|
Sun
|
19 |
17 |
20 |
25 |
21 |
Fri 29 March 2024
Bratislava (SK)
3/5°C
Wed
|
Thu
|
Fri
|
Sat
|
Sun
|
16 |
16 |
20 |
23 |
23 |
Fri 29 March 2024
Budapest (HU)
4/3°C
Wed
|
Thu
|
Fri
|
Sat
|
Sun
|
18 |
15 |
21 |
24 |
22 |
March 3rd, 2021
Mabion, a Polish biotech company, will manufacture a Covid-19 vaccine under a licence with US pharmaceutical firm Novavax. Mabion has signed a deal with Novavax for the transfer of technology and technological trials in the manufacture of an antigen for Novavax's Covid-19 vaccine which is yet to be approved by the EU's medical agency, Mabion said in a statement on Wednesday.
PAP
Pageviews this month:
41,680